Jan. 16, 2026 — MemorialCare Heart & Vascular Institute has launched the FDA-approved Symplicity Renal Denervation (RDN) procedure, a minimally invasive treatment now available at Long Beach Medical ...
Renal Denervation
This channel includes news and new technology innovations for renal denervation used to treat hypertension. Renal denervation is a catheter-based therapy. The catheter is into the renal artery and delivers radio-frequency energy to ablate the nerves in the vessel wall that regulate vasoconstriction. This leaves the vessel permanently in the widest open position to allow greater blood flow to the kidneys. This enables greater filtration of the blood and removal of excess water that causes hypertension.
-
-
Oct. 30, 2025 — Recor Medical and its parent company, Otsuka Medical Devices presented the results from two clinical studies presented at the recent 2025 Transcatheter Cardiovascular Therapeutics (TCT ...
-
Hypertension remains the leading modifiable driver of cardiovascular disease and premature death.1 Even with multiple drug classes available, nearly 70% of adults have uncontrolled blood pressure.2 ...
-
November 20, 2023 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug Administration (FDA) has approved the Symplicity Spyral renal denervation ...
March 28, 2026 — Medtronic has announced the EMBRACE trial, led by Dr. Roxana Mehran, Professor of Medicine and Director ...
March 31, 2026
Jan. 16, 2026 — MemorialCare Heart & Vascular Institute has launched the FDA-approved Symplicity Renal Denervation (RDN) ...
January 19, 2026
Oct. 30, 2025 — Recor Medical and its parent company, Otsuka Medical Devices presented the results from two clinical ...
November 03, 2025
Feature | Renal Denervation | Kyle Hardner
Hypertension remains the leading modifiable driver of cardiovascular disease and premature death.1 Even with multiple ...
October 02, 2025
July 7, 2025 — Medtronic announced that it has treated the first patient in its SPYRAL GEMINI Pilot program (including ...
July 07, 2025
At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., Medtronic presented new data and ...
March 10, 2025
Jan. 13, 2025 — Medtronic recently announced that the Centers for Medicare & Medicaid Services (CMS) is opening a ...
January 27, 2025
Jan. 13, 2025 — Medtronic plc recently announced that the Centers for Medicare & Medicaid Services (CMS) is opening a ...
January 14, 2025
November 20, 2023 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and ...
November 20, 2023
November 15, 2023 — Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced the first ...
November 15, 2023
August 21, 2023 — The Society for Cardiovascular Angiography & Interventions (SCAI) has released a position statement on ...
August 21, 2023
March 2, 2023 — ReCor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced that primary ...
March 02, 2023
January 9, 2023 — ReCor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced the appointment ...
January 09, 2023
July 29, 2022 — ReCor Medical, Inc. and Otsuka Medical Devices Co., Ltd., a fully owned subsidiary of Otsuka Holdings ...
July 29, 2022
November 9, 2021 — Six-month outcomes from the randomized RADIANCE-HTN TRIO Trial comparing endovascular ultrasound ...
November 09, 2021